Search
  1. Home
  2. Southern Africa
  3. Zambia

Expensive tests hamper AIDS drug uptake

    JOHANNESBURG

    Research presented at an AIDS conference in South Africa says that despite the availability of anti-AIDS drugs in Zambia since 2002, few people had joined the national treatment programme.

    Namposya Nampanya-Serpell, author of the research paper, "Access to Treatment and ARV Uptake in Zambia", remarked at the Second African Conference on Social Aspects of Access to Care and Treatment in Cape Town that just over 4,000 Zambians were currently on antiretroviral treatment.

    She told the UN news service, PlusNews, that although antiretrovirals were relatively cheap in Zambia, they were only accessible after both a CD4 test, costing US $40, and a viral load test, for US $30, were carried out.

    "The doctors that are responsible for the rollout of antiretroviral therapy insist on both tests, so the initial outlay is very expensive," Nampanya-Serpell said.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join